Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
BioVie ( (BIVI) ) has provided an update.
BioVie Inc., a clinical-stage company developing treatments for chronic conditions, has successfully closed a direct offering and private placement, raising approximately $6 million. The funds will be primarily used for working capital and general corporate purposes. This strategic financial move reflects BioVie’s ongoing commitment to advancing its innovative drug therapies, including those for neurodegenerative disorders and liver disease, amidst market uncertainties and potential risks.
See more insights into BIVI stock on TipRanks’ Stock Analysis page.
